Kaplan G
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021.
Immunol Lett. 1988 Nov;19(3):223-7. doi: 10.1016/0165-2478(88)90146-0.
The inability of lepromatous leprosy patients to mount a cellular immune response against Mycobacterium leprae antigens is not understood. The extensive intracellular replication of bacilli in the phagocytes and the relative paucity of T lymphocytes in the lesions suggest that these patients might be incapable of generating normal delayed type hypersensitivity responses in their skin. In order to elucidate this problem we evaluated the patient's response to local antigen administration. Our observations suggest that the majority of lepromatous patients can respond normally to intradermal injections of a soluble antigen such as purified protein derivative of tuberculin. The underlying lepromatous lesions do not inhibit mononuclear cell infiltration or differentiation. Moreover, the generation of a cellular immune response in the lesions appears to modify the lepromatous lesion to a lesion resembling the tuberculoid type. This process involves local T cells recruitment, granuloma formation and a reduction in the bacterial load at the antigen responsive site.
瘤型麻风患者无法针对麻风分枝杆菌抗原产生细胞免疫反应,其原因尚不清楚。杆菌在吞噬细胞中广泛的细胞内复制以及病变部位T淋巴细胞相对较少,这表明这些患者可能无法在其皮肤中产生正常的迟发型超敏反应。为了阐明这个问题,我们评估了患者对局部抗原给药的反应。我们的观察结果表明,大多数瘤型患者对皮内注射可溶性抗原(如结核菌素纯蛋白衍生物)能做出正常反应。潜在的瘤型病变不会抑制单核细胞浸润或分化。此外,病变部位细胞免疫反应的产生似乎会将瘤型病变转变为类似结核样型的病变。这个过程涉及局部T细胞募集、肉芽肿形成以及抗原反应部位细菌载量的减少。